TAKE A LOOK-U.S. Treasury Department takes new steps to curb 'inversions'

Tue Apr 5, 2016 5:52pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 5 (Reuters) - The U.S. Treasury Department took new steps to curb tax-avoiding
corporate "inversions," with the pending $160 billion merger of Pfizer Inc and Allergan
Plc seen as a potential casualty. 
> U.S. Treasury rules put Pfizer-Allergan deal in question                  
> EXCLUSIVE-Pfizer leaning towards abandoning deal with Allergan -source    
> President Obama urges Congress to take action on corporate tax reform     
> Inversion rule fallout hits boutique advisory firms                       
> New U.S. tax-inversion rules weigh on agreed deals                        
> Uncle Sam's anti-inversion hunt may bag big trophy                        
> U.S. Companies doing tax inversions have wide-ranging motives             
> U.S. House Democrats introduce bill to curb company tax inversions        
> U.S. politicians slam tax-avoiding Pfizer-Allergan deal                   
> Pfizer to buy Allergan in $160 billion deal                               

 (Compiled by Americas Desk)